Subtopic Deep Dive

← Medicinal Plant Pharmacodynamics Research

Icariin Anticancer Activity
Research Guide

What is Icariin Anticancer Activity?

Icariin anticancer activity studies the mechanisms by which icariin and its derivatives from Epimedium inhibit tumor proliferation, induce apoptosis, and suppress metastasis via pathways like JAK/STAT and NF-κB.

Icariin targets multiple signaling pathways in cancer cells, including SIRT6/NF-κB in triple-negative breast cancer (Song et al., 2020, 173 citations) and IL-6/Jak2/Stat3 in hepatocellular carcinoma (Zhao et al., 2015, 150 citations). Research spans breast, endometrial, renal, and leukemia models with over 1,500 citations across 15 key papers. Derivatives like icaritin and icariside II enhance these effects (Tan et al., 2016, 147 citations).

Curated Papers

Key Challenges

Why It Matters

Icariin suppresses tumor growth in triple-negative breast cancer by inhibiting SIRT6/NF-κB and enhancing anti-tumor immunity (Song et al., 2020). Icaritin blocks JAK/STAT3 signaling in renal cell carcinoma, reducing proliferation and angiogenesis (Li et al., 2013, 115 citations), and activates sustained ERK1/2 for apoptosis in endometrial cancer (Tong et al., 2011, 138 citations). These mechanisms support flavonoid-based therapies for resistant cancers, as reviewed in Tan et al. (2016) covering aphrodisiac derivatives' anti-cancer properties.

Key Research Challenges

Pathway Specificity

Icariin modulates multiple pathways like JAK/STAT3 and NF-κB, complicating isolation of primary anticancer targets (Zhao et al., 2015; Song et al., 2020). Determining dominant mechanisms in specific cancers remains unresolved. Citation analysis shows overlapping effects across models.

Derivative Bioavailability

Icaritin and icariside II show potency but face absorption barriers in vivo (Khan et al., 2015, 141 citations; Lu et al., 2022, 137 citations). Nanotechnology integration is proposed but unoptimized (Lu et al.). Clinical translation lags preclinical data.

Clinical Translation Gaps

Preclinical efficacy in models like leukemia and hepatocellular carcinoma lacks human trials (Zhu et al., 2011, 80 citations; Zhao et al., 2015). Resistance mechanisms and dosing in patients are untested. Over 500 citations highlight in vitro dominance.

Essential Papers

Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis

Jianbo He, Xiaojuan Li, Ziyi Wang et al. · 2019 · Frontiers in Pharmacology · 178 citations

Osteoporosis is a bone disease characterized by increasing osseous fragility and fracture due to the reduced bone mass and microstructural degradation. Primary pharmacological strategies for the tr...

Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer

Linjiang Song, Xian Chen, Ling Mi et al. · 2020 · Cancer Science · 173 citations

Abstract Abnormal activation of the nuclear factor‐kappa B (NF‐κB) signaling pathway is closely implicated in triple‐negative breast cancer growth, metastasis, and tumor immune escape. In this stud...

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway

Hong Zhao, Yuming Guo, Shu Li et al. · 2015 · Oncotarget · 150 citations

Tumor-initiating cell (TIC) is a subpopulation of cells in tumors that are responsible for tumor initiation and progression. Recent studies indicate that hepatocellular carcinoma-initiating cells (...

Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives

Huı Tan, Kok‐Gan Chan, Priyia Pusparajah et al. · 2016 · Frontiers in Pharmacology · 147 citations

Epimedium (family Berberidaceae), commonly known as Horny Goat Weed or Yin Yang Huo, is commonly used as a tonic, aphrodisiac, anti-rheumatic and anti-cancer agent in traditional herbal formulation...

Herba Epimedii: Anti-Oxidative Properties and Its Medical Implications

Stephen Cho Wing Sze, Yao Tong, Tzi Bun Ng et al. · 2010 · Molecules · 146 citations

Herba Epimedii is a Chinese herbal medicine with proven efficacy in treating cardiovascular diseases and osteoporosis, and in improving sexual and neurological functions. This efficacy is found to ...

Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells

Muhammad Noman Khan, Amara Maryam, Javed Iqbal Qazi et al. · 2015 · International Journal of Biological Sciences · 141 citations

Cancer is the second leading cause of deaths worldwide. Despite concerted efforts to improve the current therapies, the prognosis of cancer remains dismal. Highly selective or specific blocking of ...

Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells

Jingshan Tong, Qinghua Zhang, Xin Huang et al. · 2011 · PLoS ONE · 138 citations

Icaritin, a compound from Epimedium Genus, has selective estrogen receptor (ER) modulating activities, and possess anti-tumor activity. Here, we examined icaritin effect on cell growth of human end...

Reading Guide

Foundational Papers

Read Sze et al. (2010, 146 citations) first for anti-oxidative basis of Herba Epimedii; Tong et al. (2011, 138 citations) for icaritin apoptosis in endometrial cancer; Li et al. (2013, 115 citations) for JAK/STAT3 in renal carcinoma to establish core mechanisms.

Recent Advances

Study Song et al. (2020, 173 citations) for SIRT6/NF-κB in breast cancer; Lu et al. (2022, 137 citations) for nanotechnology enhancements; Luo et al. (2020, 117 citations) for ferroptosis links.

Core Methods

Core methods: MTT assays for proliferation, flow cytometry for apoptosis, Western blots for pathway phosphorylation (e.g., STAT3, NF-κB), xenograft models, and molecular docking for binding (Song et al., 2020; Zhao et al., 2015).

How PapersFlow Helps You Research Icariin Anticancer Activity

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to find icariin papers like Song et al. (2020) on SIRT6/NF-κB in breast cancer, then citationGraph maps connections to Zhao et al. (2015) on JAK/STAT3, and findSimilarPapers uncovers related flavonoid studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract mechanisms from Song et al. (2020), verifies claims with CoVe against Li et al. (2013), and runs PythonAnalysis on dose-response data from Tan et al. (2016) for IC50 statistics using GRADE for evidence strength in apoptosis pathways.

Synthesize & Write

Synthesis Agent detects gaps like bioavailability limits in Lu et al. (2022), flags contradictions between ERK activation models (Tong et al., 2011 vs. Khan et al., 2015), and Writing Agent uses latexEditText, latexSyncCitations for icariin reviews, latexCompile for pathway figures, and exportMermaid for JAK/STAT diagrams.

Use Cases

"Extract IC50 values for icariin in breast cancer apoptosis from top papers and plot dose-response curve."

Research Agent → searchPapers('icariin breast cancer IC50') → Analysis Agent → readPaperContent(Song 2020) + runPythonAnalysis(pandas plot IC50 curve) → matplotlib graph of efficacy.

"Draft LaTeX review section on icariin JAK/STAT inhibition with citations and pathway diagram."

Synthesis Agent → gap detection(JAK/STAT papers) → Writing Agent → latexEditText('icariin JAK/STAT') → latexSyncCitations(Zhao 2015, Li 2013) → latexCompile + exportMermaid(STAT3 diagram).

"Find GitHub repos implementing icariin signaling models from recent papers."

Research Agent → citationGraph(Song 2020) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(JAK/STAT simulations).

Automated Workflows

Deep Research workflow conducts systematic review of 50+ icariin papers via searchPapers → citationGraph → structured report on pathways like NF-κB (Song et al., 2020). DeepScan applies 7-step analysis with CoVe checkpoints to verify apoptosis claims in Tong et al. (2011). Theorizer generates hypotheses on icariin synergy with gemcitabine from Zhang et al. (2012).

Try Doxa for Icariin Anticancer Activity Research

Frequently Asked Questions

What defines icariin anticancer activity?

Icariin anticancer activity is defined as inhibition of tumor proliferation, apoptosis induction, and metastasis suppression via JAK/STAT and NF-κB pathways (Song et al., 2020; Zhao et al., 2015).

What are key methods in icariin cancer studies?

Methods include cell line assays for apoptosis (Tong et al., 2011), xenograft models for tumor growth (Li et al., 2013), and pathway inhibition via Western blot (Khan et al., 2015).

What are top papers on icariin anticancer activity?

Top papers: Song et al. (2020, 173 citations, breast cancer NF-κB); Zhao et al. (2015, 150 citations, HCC JAK/STAT3); Tan et al. (2016, 147 citations, derivatives review).

What open problems exist in icariin research?

Open problems: improving bioavailability of derivatives (Lu et al., 2022), clinical trials beyond preclinical models, and isolating pathway-specific effects (Khan et al., 2015).